Frailty, Anesthesia and Complications. (FRAC)

September 15, 2023 updated by: Merce Prieto Butillé, Fundacio Puigvert

Frailty, Anesthesia and Complications in an Urological Setting.

Objectives: To assess the prevalence of frailty in patients older than 70 y/o in nephrourologic surgery. To study if preoperative frailty is an independent predictor of immediate postoperative complications, after 30 days, 6 months and 1 year of follow-up. To detect if there are other independent risk factors for complications.

Study Overview

Detailed Description

Objectives: To assess the prevalence of frailty in patients older than 70 y/o in nephrourologic surgery. To study if preoperative frailty is an independent predictor of immediate postoperative complications, after 30 days, 6 months and 1 year of follow-up. To detect if there are other independent risk factors for complications.

Methods: prospective cohort study performed at Fundació Puigvert. Enrollment of 850 patients ≥70 y/o who undergo scheduled nephrourologic surgery. In the preoperative visit frailty is going to be evaluated using the Short Physical Performance Battery (SPPB), the Canadian Frailty Scale, the Mini-Cog test (Memory an executive functions), the Pfeiffer Test (Cognitive global screening), an involuntary loss of more than 4.5kg or 5% of weight in the previous year and physical activity using the Metabolic Equivalents of Task (MET). We will analyse the relation among frailty, medical, surgical postoperative complications and mortality at 30 days, 6 months and one year after the surgery.

The results will be adjusted by the possible confounding and interaction variables using a multivariate logistic regression model. The confounding /interaction variables will include demographic data, clinical and lab data and events arisen during the follow-up period.

Study Type

Observational

Enrollment (Actual)

413

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08025
        • Fundacio Puigvert

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing urological scheduled surgery in our centre, that fill in the inclusion criteria with no exclusion criteria.

Description

Inclusion criteria

  • Patients who participate voluntarily
  • Signed Informed consent
  • 70+ years old
  • Scheduled urological surgery with general or regional anesthesia and length of stay in hospital over 24 hours.
  • Patients with preserved domiciliary deambulation without aid of another person. (walking sticks, or walkers are accepted)

Exclusion Criteria:

  • No signing of the informed consent
  • Surgery performed with local anesthetics
  • Day surgery, extracorporeal wave lithotripsy or endourological catheterism
  • Advanced diagnosed dementia
  • Patients with chronic advanced disease or terminal oncological disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty as a risk factor of postoperative events.
Time Frame: 2017-2021
Assessment the prevalence of frailty in the surgical settings defined as a clinically recognizable state of increased vulnerability resulting from aging-associated decline in reserve and function across multiple physiologic systems. Frailty is defined as meeting three out of five phenotypic criteria indicating compromised energetics: low grip strength, low energy, slowed waking speed, low physical activity, and/or unintentional weight loss
2017-2021
Frailty will be evaluated during the preoperative visit of patients 70+ scheduled to uronephrologic surgery
Time Frame: 2017-2021
Frailty is going to be evaluated in the anesthetic preoperative visit using the Short Physical Performance Battery (SPPB), Canadian Frailty Scale, Mini-Cog test (Memory an executive functions), Pfeiffer Test (Cognitive global screening), Involuntary loose of more than 4,5kg or 5% of weight in the previous year, physical activity using the Metabolic Equivalents of Task (MET).
2017-2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative events and frailty
Time Frame: 2017-2021
Assessment of the association among frailty, medical and surgical postoperative complications at 30 days, 6 months and one year after the surgery.
2017-2021
Mortality associated to frailty and its complications
Time Frame: 2017-2021
Assessment of the association between frailty and mortality at 30 days, 6 months and one year after the surgery.
2017-2021
Preoperative visit as a chance to assess frailty
Time Frame: 2017-2021
Analyze which frailty evaluation tool works better in the preoperative visit setting.
2017-2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sergi Sabate, MD PhD, Chair Anesthesiologist at Fundació Puigvert

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

February 1, 2021

Study Completion (Actual)

January 1, 2023

Study Registration Dates

First Submitted

January 3, 2019

First Submitted That Met QC Criteria

February 8, 2020

First Posted (Actual)

February 11, 2020

Study Record Updates

Last Update Posted (Actual)

September 18, 2023

Last Update Submitted That Met QC Criteria

September 15, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly Syndrome

Subscribe